Experimental results from PCa cells with either overexpression or knockdown of SOX2 suggest that directly targeting the SOX2 transcription factor could be a promising strategy for inhibiting tumor initiation and progression. The gene discussed is SOX2; the disease is posterior cortical atrophy.